| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. (APRE) has 10 insiders with recent SEC Form 4 filings, including 9 buys and 14 sells. APRE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 259.3K | $205.9K | - | |
| Dir | 48.9K | $38.8K | - | |
| CFO | 27.7K | $22.0K | - | |
| CEO | 21.5K | $17.0K | - | |
| Dir | 13.4K | $10.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2020 | 5am Ventures Iv, L.P. | 10% Owner | Sell | 140,000 | $33.30 | $4,662,000.00 | -6.0% | |
| Jun 16, 2020 | Rocklage Scott M | Director, 10% Owner | Sell | 120,164 | $33.30 | $4,001,461.20 | -6.0% | |
| Jun 11, 2020 | 5am Ventures Iv, L.P. | 10% Owner | Sell | 245,000 | $28.75 | $7,044,411.50 | -10.8% | |
| Jun 11, 2020 | Rocklage Scott M | Director, 10% Owner | Sell | 245,000 | $28.75 | $7,044,411.50 | -10.8% | |
| May 19, 2020 | 5am Ventures Iv, L.P. | 10% Owner | Sell | 255,000 | $35.15 | $8,963,250.00 | -10.1% | |
| May 19, 2020 | Rocklage Scott M | Director | Sell | 255,000 | $35.15 | $8,963,250.00 | -10.1% | |
| Apr 13, 2020 | Kdev Investments Ab | 10% Owner | Sell | 210,548 | $31.25 | $6,579,625.00 | -8.6% | |
| Oct 7, 2019 | 5am Ventures Iv, L.P. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | New | |
| Oct 7, 2019 | Schade Christian S | President &CEO | Buy | 11,000 | $15.00 | $165,000.00 | New | |
| Oct 7, 2019 | Henneman John B III | Director | Buy | 5,000 | $15.00 | $75,000.00 | New |